ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MYGN Myriad Genetics Inc

18.92
-0.25 (-1.30%)
After Hours
Last Updated: 17:54:43
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Myriad Genetics Inc MYGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.25 -1.30% 18.92 17:54:43
Open Price Low Price High Price Close Price Prev Close
19.06 18.50 19.12 18.92 19.17
more quote information »

Recent News

Date Time Source Heading
4/16/20248:52IHNWFeaturedCannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
4/16/202409:15GLOBENew Myriad Genetics Study Published in Prenatal Diagnosis..
4/09/202408:00GLOBEMyriad Genetics Research Shows Reduction in Hospitalizations..
3/21/202421:40GLOBEMyriad Genetics Announces Foundational Patent Granted for..
3/20/202416:05GLOBEMyriad Genetics Announces Patent Granted for SneakPeek® Snap..
3/04/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202408:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/27/202416:05EDGAR2Form 8-K - Current report
2/27/202416:05GLOBEMyriad Genetics Reports Strong Fourth Quarter and Full-Year..
2/27/202409:15GLOBEMyriad Genetics and National Cancer Center Hospital East in..
2/26/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202416:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202416:05GLOBEMyriad Genetics to Release Fourth Quarter and Full Year 2023..
2/15/202416:05GLOBEMyriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as..
2/14/202416:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202408:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202410:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/01/202409:25GLOBEMyriad Genetics Completes Acquisition of Precise Tumor,..
1/31/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202417:00GLOBEMyriad Genetics Names George Daneker Jr., MD, as President..
1/29/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/29/202416:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/23/202416:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/22/202414:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/18/202418:10GLOBEMyriad Genetics to Acquire Precise Tumor, Precise Liquid and..
1/16/202409:00EDGAR2Form 8-K - Current report
1/09/202416:05GLOBEMyriad Genetics Applauds New Germline Testing Guideline for..
1/03/202416:05GLOBEMyriad Genetics to Present at 42nd Annual J.P. Morgan..
1/02/202417:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202308:30EDGAR2Form 8-K - Current report
12/21/202308:30GLOBEMyriad Genetics Chief Financial Officer Bryan Riggsbee..
12/20/202308:00GLOBEMyriad Genetics Establishes Comprehensive Pan-Cancer..
12/11/202318:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202318:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/05/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202316:05GLOBEMyriad Genetics Celebrates One Million SneakPeek® Results..
11/16/202316:05GLOBEMyriad Genetics and Personalis Partner to Market..
11/13/202316:31EDGAR2Form 8-K - Current report
11/13/202306:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/09/202307:00GLOBEMyriad Genetics to Participate in Stephens Annual Investment..
11/08/202321:20GLOBEMyriad Genetics Announces Pricing of Upsized Offering of..
11/08/202321:16EDGAR2Form 8-K - Current report
11/08/202316:10GLOBEMyriad Genetics Announces Proposed Offering of $100 Million..
11/08/202316:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/08/202316:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/07/202308:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202316:05EDGAR2Form 8-K - Current report
11/06/202316:05GLOBEMyriad Genetics Reports Third Quarter 2023 Financial..
11/03/202317:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202321:00EDGAR2Form 144 - Report of proposed sale of securities
11/01/202316:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock